Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: Tmax (time to maximum concentration)

BA-BE Studies: SOP for Re-Dosing in Cross-Over Study Designs – V 2.0

Posted on By

BA-BE Studies: SOP for Re-Dosing in Cross-Over Study Designs – V 2.0 Standard Operating Procedure for Re-Dosing in Cross-Over Study Designs in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/070/2025 Supersedes SOP/BA-BE/070/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a clear and compliant…

Read More “BA-BE Studies: SOP for Re-Dosing in Cross-Over Study Designs – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Clinical Documentation of Adverse Events – V 2.0

Posted on By

BA-BE Studies: SOP for Clinical Documentation of Adverse Events – V 2.0 Standard Operating Procedure for Clinical Documentation of Adverse Events in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/069/2025 Supersedes SOP/BA-BE/069/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the standardized procedure for…

Read More “BA-BE Studies: SOP for Clinical Documentation of Adverse Events – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Handling Serious Adverse Events (SAEs) – V 2.0

Posted on By

BA-BE Studies: SOP for Handling Serious Adverse Events (SAEs) – V 2.0 Standard Operating Procedure for Handling Serious Adverse Events (SAEs) in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/068/2025 Supersedes SOP/BA-BE/068/2022 Page No. Page 1 of 11 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To provide a clear, standardized procedure…

Read More “BA-BE Studies: SOP for Handling Serious Adverse Events (SAEs) – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for First-Aid Management of Mild Reactions – V 2.0

Posted on By

BA-BE Studies: SOP for First-Aid Management of Mild Reactions – V 2.0 Standard Operating Procedure for First-Aid Management of Mild Reactions in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/067/2025 Supersedes SOP/BA-BE/067/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a clear and systematic…

Read More “BA-BE Studies: SOP for First-Aid Management of Mild Reactions – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Periodic Clinical Safety Assessments – V 2.0

Posted on By

BA-BE Studies: SOP for Periodic Clinical Safety Assessments – V 2.0 Standard Operating Procedure for Periodic Clinical Safety Assessments in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/066/2025 Supersedes SOP/BA-BE/066/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a standard operating procedure for conducting…

Read More “BA-BE Studies: SOP for Periodic Clinical Safety Assessments – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Monitoring Vital Signs During Clinical Phase – V 2.0

Posted on By

BA-BE Studies: SOP for Monitoring Vital Signs During Clinical Phase – V 2.0 Standard Operating Procedure for Monitoring Vital Signs During Clinical Phase in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/065/2025 Supersedes SOP/BA-BE/065/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the standard…

Read More “BA-BE Studies: SOP for Monitoring Vital Signs During Clinical Phase – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Observing Post-Dose Adverse Events – V 2.0

Posted on By

BA-BE Studies: SOP for Observing Post-Dose Adverse Events – V 2.0 Standard Operating Procedure for Observing Post-Dose Adverse Events in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/064/2025 Supersedes SOP/BA-BE/064/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a systematic approach for monitoring, identifying,…

Read More “BA-BE Studies: SOP for Observing Post-Dose Adverse Events – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Supervision of Dosing Procedures – V 2.0

Posted on By

BA-BE Studies: SOP for Supervision of Dosing Procedures – V 2.0 Standard Operating Procedure for Supervision of Dosing Procedures in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/063/2025 Supersedes SOP/BA-BE/063/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To describe the procedure for the supervision of…

Read More “BA-BE Studies: SOP for Supervision of Dosing Procedures – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Water Intake Restrictions and Management – V 2.0

Posted on By

BA-BE Studies: SOP for Water Intake Restrictions and Management – V 2.0 Standard Operating Procedure for Water Intake Restrictions and Management in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/062/2025 Supersedes SOP/BA-BE/062/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a standardized procedure for…

Read More “BA-BE Studies: SOP for Water Intake Restrictions and Management – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0

Posted on By

BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0 Standard Operating Procedure for Meal Composition and Timing for Fed Studies in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/061/2025 Supersedes SOP/BA-BE/061/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define…

Read More “BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0” »

BA-BE Studies V 2.0

Posts pagination

Previous 1 … 4 5 6 … 16 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme